A detailed history of Tower Research Capital LLC (Trc) transactions in Lantern Pharma Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 1,515 shares of LTRN stock, worth $5,363. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,515
Previous 1,339 13.14%
Holding current value
$5,363
Previous $6,000 16.67%
% of portfolio
0.0%
Previous 0.0%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$3.42 - $4.83 $601 - $850
176 Added 13.14%
1,515 $5,000
Q2 2024

Aug 13, 2024

SELL
$3.91 - $9.51 $7,886 - $19,181
-2,017 Reduced 60.1%
1,339 $6,000
Q1 2024

May 15, 2024

BUY
$3.73 - $10.65 $8,176 - $23,344
2,192 Added 188.32%
3,356 $29,000
Q4 2023

Feb 13, 2024

SELL
$2.48 - $4.39 $1,718 - $3,042
-693 Reduced 37.32%
1,164 $4,000
Q3 2023

Nov 14, 2023

SELL
$3.41 - $5.51 $1,643 - $2,655
-482 Reduced 20.61%
1,857 $6,000
Q2 2023

Aug 14, 2023

BUY
$4.56 - $6.02 $1,012 - $1,336
222 Added 10.49%
2,339 $13,000
Q1 2023

May 09, 2023

BUY
$4.3 - $6.2 $8,982 - $12,951
2,089 Added 7460.71%
2,117 $10,000
Q4 2022

Feb 10, 2023

SELL
$4.19 - $6.04 $15,875 - $22,885
-3,789 Reduced 99.27%
28 $0
Q3 2022

Nov 10, 2022

BUY
$4.59 - $6.5 $12,347 - $17,485
2,690 Added 238.69%
3,817 $19,000
Q2 2022

Aug 15, 2022

BUY
$4.82 - $7.45 $1,706 - $2,637
354 Added 45.8%
1,127 $6,000
Q1 2022

May 12, 2022

SELL
$5.6 - $8.22 $4,698 - $6,896
-839 Reduced 52.05%
773 $6,000
Q4 2021

Feb 14, 2022

BUY
$7.11 - $11.04 $7,693 - $11,945
1,082 Added 204.15%
1,612 $13,000
Q3 2021

Nov 15, 2021

BUY
$10.53 - $14.93 $1,874 - $2,657
178 Added 50.57%
530 $6,000
Q2 2021

Aug 16, 2021

BUY
$12.94 - $19.89 $3,752 - $5,768
290 Added 467.74%
352 $5,000
Q1 2021

May 17, 2021

SELL
$14.34 - $21.92 $7,614 - $11,639
-531 Reduced 89.54%
62 $1,000
Q4 2020

Feb 16, 2021

SELL
$15.1 - $20.69 $1,751 - $2,400
-116 Reduced 16.36%
593 $11,000
Q3 2020

Nov 16, 2020

BUY
$10.7 - $21.25 $5,767 - $11,453
539 Added 317.06%
709 $13,000
Q2 2020

Aug 13, 2020

BUY
$11.54 - $14.95 $1,961 - $2,541
170 New
170 $2,000

Others Institutions Holding LTRN

About Lantern Pharma Inc.


  • Ticker LTRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 10,830,900
  • Market Cap $38.3M
  • Description
  • Lantern Pharma Inc., a clinical stage biotechnology company, focuses on artificial intelligence, machine learning, and genomic data to streamline the drug development process. Its advanced drug candidate is LP-100, which is in phase II clinical trials to treat metastatic, castration-resistant, and prostate cancer. The company also develops LP-30...
More about LTRN
Track This Portfolio

Track Tower Research Capital LLC (Trc) Portfolio

Follow Tower Research Capital LLC (Trc) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.